Joren R. Ten Hove
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joren R. Ten Hove has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Andrea E. van der Meulen-De Jong
Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication- Bas Oldenburg
Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands
1 shared publication - Bas Oldenburg
Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands
1 shared publication - Bas Oldenburg
Department of Gastroenterology and Hepatology, University Medical Center Utrecht , 3584 CX Utrecht
1 shared publication Cyriel Y. Ponsioen
Department of Gastroenterology and Hepatology, Amsterdam Medical Center, Amsterdam, The Netherlands
1 shared publicationErik Mooiweer
Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 August 2018
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 25 (2) , 377-384
Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease
Patients with refractory inflammatory bowel disease (IBD) might require a subtotal colectomy with construction of an ileostomy. Due to the risk of nerve damage and pelvic sepsis, the diverted rectum is often left in situ. Evidence on long-term complications of this rectal stump is limited, particularly in patients with Crohn’s disease (CD). In addition to the risk of development of neoplasia, diversion proctitis is a frequently reported rectal stump associated complication. Surprisingly, clear recommendations concerning rectal stump surveillance and timing of proctectomy are lacking. Through the use of a pathology database and a review of medical records, we established a cohort of IBD patients with a diverted rectum. Among these patients, long-term complications of the rectal stump were identified. Main endpoint was advanced neoplasia (carcinoma or high-grade dysplasia [HGD]) in the rectal stump. Risk factors for advanced neoplasia were identified using Cox regression modeling. In the second, prospective part of the study, a questionnaire was sent out to 165 patients with either a rectal stump in situ or who had undergone a proctectomy, in order to identify differences in patient-reported outcome measures associated with the excision of the rectal stump. From 530 patients with IBD and a (temporal) diversion of the rectum, we included 250 patients in whom the rectal stump was left in situ for more than 12 months. The majority of patients was female (61%) and had Crohn’s disease (67%). On follow-up (median 8 years), 8 carcinomas, 2 cases of high-grade dysplasia, and 7 cases of low-grade dysplasia were found with incidence rates of 3.9 and 8.5 per 1000 patient-years of follow-up for cancer and all neoplasia, respectively. The 8 cases of rectal stump cancer (RSC) were diagnosed after a median of 15 years after colectomy. A history of colorectal neoplasia was associated with advanced rectal stump neoplasia. Out of 191 patients with endoscopic follow-up, rectal stump inflammation occurred in 161 (88.5%) patients. Results of the questionnaire did not show a significant difference in quality of life between patients with and patients without a rectal stump, although the latter group reported significantly more sexual and urinary symptoms than patients with a rectal stump in situ. The majority of rectal stump patients reported rectal blood loss, but 65.5% of them were not or barely limited in daily life by their rectal stumprelated problems. Rectal stump cancer has a low incidence rate, with patients with a history of colonic neoplasia carrying the highest risk of developing this severe complication. We observed no significant differences in quality of life between rectal stump and postproctectomy patients, but proctectomy surgery is associated with sexual and urinary complications.
- 1 August 2018
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 25 (2) , 377-384
Open AccessMalignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease
Patients with refractory inflammatory bowel disease (IBD) might require a subtotal colectomy with construction of an ileostomy. Due to the risk of nerve damage and pelvic sepsis, the diverted rectum is often left in situ. Evidence on long-term complications of this rectal stump is limited, particularly in patients with Crohn’s disease (CD). In addition to the risk of development of neoplasia, diversion proctitis is a frequently reported rectal stump associated complication. Surprisingly, clear recommendations concerning rectal stump surveillance and timing of proctectomy are lacking. Through the use of a pathology database and a review of medical records, we established a cohort of IBD patients with a diverted rectum. Among these patients, long-term complications of the rectal stump were identified. Main endpoint was advanced neoplasia (carcinoma or high-grade dysplasia [HGD]) in the rectal stump. Risk factors for advanced neoplasia were identified using Cox regression modeling. In the second, prospective part of the study, a questionnaire was sent out to 165 patients with either a rectal stump in situ or who had undergone a proctectomy, in order to identify differences in patient-reported outcome measures associated with the excision of the rectal stump. From 530 patients with IBD and a (temporal) diversion of the rectum, we included 250 patients in whom the rectal stump was left in situ for more than 12 months. The majority of patients was female (61%) and had Crohn’s disease (67%). On follow-up (median 8 years), 8 carcinomas, 2 cases of high-grade dysplasia, and 7 cases of low-grade dysplasia were found with incidence rates of 3.9 and 8.5 per 1000 patient-years of follow-up for cancer and all neoplasia, respectively. The 8 cases of rectal stump cancer (RSC) were diagnosed after a median of 15 years after colectomy. A history of colorectal neoplasia was associated with advanced rectal stump neoplasia. Out of 191 patients with endoscopic follow-up, rectal stump inflammation occurred in 161 (88.5%) patients. Results of the questionnaire did not show a significant difference in quality of life between patients with and patients without a rectal stump, although the latter group reported significantly more sexual and urinary symptoms than patients with a rectal stump in situ. The majority of rectal stump patients reported rectal blood loss, but 65.5% of them were not or barely limited in daily life by their rectal stumprelated problems. Rectal stump cancer has a low incidence rate, with patients with a history of colonic neoplasia carrying the highest risk of developing this severe complication. We observed no significant differences in quality of life between rectal stump and postproctectomy patients, but proctectomy surgery is associated with sexual and urinary complications.
- 1 February 2017
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (2) , 222-228.e2
Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases
- 1 February 2017
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (2) , 222-228.e2
Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases
- 1 August 2015
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 29 (4) , 687-697
Surveillance of long-standing colitis: The role of image-enhanced endoscopy
- 1 August 2015
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 29 (4) , 687-697
Surveillance of long-standing colitis: The role of image-enhanced endoscopy